Hormone-refractory Prostate Cancer
2 competing products in clinical development for Hormone-refractory Prostate Cancer.
Pipeline by Phase
Phase 22
All Products (2)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| Enzalutamide | Astellas Pharma | Phase 2 | Completed | 35 |
| YM598 | Astellas Pharma | Phase 2 | Terminated | 27 |